Chlorambucil and acute intermittent porphyria

Clinical Oncology

Volumn 14, Issue 6, 2002, Pages 491-493

  Davies, J H ^a   Whitaker, S J ^a  

^a ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

Author keywords

Acute intermittent porphyria; Chlorambucil; Non Hodgkin's lymphoma

Indexed keywords

CHLORAMBUCIL; HEME ARGINATE; PORPHOBILINOGEN; PREDNISOLONE; PROTOPORPHYRIN; UROBILINOGEN;

ACUTE INTERMITTENT PORPHYRIA; ARTICLE; B CELL LYMPHOMA; CANCER GRADING; CANCER GROWTH; CASE REPORT; CASE STUDY; FEMALE; FOLLICULAR LYMPHOMA; HUMAN; LYMPH NODE BIOPSY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL;

EID: 0036893772     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1053/clon.2002.0104     Document Type: Article

References (6)

1. Manzione NC, Wolkoff AW, Sassa S. Development of porphyria cutanea tarda after treatment with cyclophosphamide. Gastroenterology 1998; 95:1119-22
2. Kyle RA, Dameskek W. Porphyria cutanea tarda associated with chronic granulocytic leakaemia treated with busulfan (Myleran). Blood. 1964;23:776-85.
3. Arbous M. Relationship between porphyria and the use of antineoplastics. Am J Hosp Pharm 1981;38:631.
4. Weheimer A, Fischer JT, Goerz G, Schneider W. Polychemotherapy of acute myclogenous leukemia in a patient with acute intermittent porphyria. Klinische Wochenschrift 1987;65(7):338-340.
5. Samuels B, Bezwoda WR, Derman DP, Ross G. Chemotherapy in porphyria. South African Medical Journal 65:924-927.
6. Cochon AC, Aldonatti C, Wainstok de Calmanovici R, San Martin de Viale LC. J of Appl Tox 1997; 17(3):171-177.